Clinical Trials Directory

Trials / Completed

CompletedNCT04776083

Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients

Role of Radiotherapy to the Primary Lesion in Metastatic Non-small Cell Lung Cancer Patients After First Line Systemic Therapy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

study the effect of radiotherapy to the primary lesion after first line systemic therapy in metastatic non-small cell lung cancer patients.

Detailed description

Metastatic non-small cell lung cancer patients after receiving their first line systemic therapy according to their genetic mutation will be randomized to follow up versus radiotherapy to the primary lesion.

Conditions

Interventions

TypeNameDescription
DRUGfirst line systemic therapyfirst line systemic therapy according to the genetic mutation 0f the patient
RADIATION3D radiotherapy or IMRTHypo-fractionated radiotherapy to the primary lesion

Timeline

Start date
2020-09-25
Primary completion
2023-11-25
Completion
2023-11-25
First posted
2021-03-01
Last updated
2024-09-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04776083. Inclusion in this directory is not an endorsement.